Skip to content

Drug interactions

Apixaban + Defibrotide

Severity: Contraindicated

Apixaban and Defibrotide: contraindicated interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Defibrotide has antithrombotic and profibrinolytic effects, so adding apixaban increases the risk of serious bleeding. Defibrotide labeling contraindicates concurrent systemic anticoagulants.

What this interaction means in plain words

Apixaban and Defibrotide are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Apixaban belongs to Cardiovascular; Defibrotide belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Additive pharmacodynamic effects on hemostasis from factor Xa inhibition plus enhanced fibrinolysis.

What to do

Do not co-administer; interrupt apixaban during defibrotide therapy under specialist guidance. Central line maintenance is the usual exception.

What to ask your pharmacist

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Apixaban and Defibrotide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Apixaban with Defibrotide?

MediHelp rates the interaction as contraindicated. Apixaban and Defibrotide are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Defibrotide has antithrombotic and profibrinolytic effects, so adding apixaban increases the risk of serious bleeding. Defibrotide labeling contraindicates concurrent systemic anticoagulants.

How serious is the interaction between Apixaban and Defibrotide?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not co-administer; interrupt apixaban during defibrotide therapy under specialist guidance. Central line maintenance is the usual exception.

What other medicines interact with Apixaban?

MediHelp also lists interactions of Apixaban with, for example, Dabigatran, Edoxaban, Ketorolac. The full list is on the Apixaban page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in